Your browser doesn't support javascript.
loading
Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).
Bocquier, Aurélie; Bruel, Sébastien; Michel, Morgane; Le Duc-Banaszuk, Anne-Sophie; Bonnay, Stéphanie; Branchereau, Marion; Chevreul, Karine; Chyderiotis, Sandra; Gauchet, Aurélie; Giraudeau, Bruno; Hagiu, Dragos-Paul; Mueller, Judith E; Gagneux-Brunon, Amandine; Thilly, Nathalie.
Afiliação
  • Bocquier A; APEMAC, Université de Lorraine, Nancy, France.
  • Bruel S; Department of General Practice, Jacques Lisfranc Faculty of Medicine, Saint-Etienne-Lyon University, Saint-Etienne, France.
  • Michel M; Health, Systemic, Process UR 4129 Research Unit, University Claude Bernard, University of Lyon, Lyon, France.
  • Le Duc-Banaszuk AS; ECEVE UMR 1123, Université de Paris Cité, Paris, France.
  • Bonnay S; Assistance Publique-Hôpitaux de Paris, Hôtel Dieu, URC Eco Ile-de-France/Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.
  • Branchereau M; Centre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.
  • Chevreul K; APEMAC, Université de Lorraine, Nancy, France.
  • Chyderiotis S; Centre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.
  • Gauchet A; ECEVE UMR 1123, Université de Paris Cité, Paris, France.
  • Giraudeau B; Assistance Publique-Hôpitaux de Paris, Hôtel Dieu, URC Eco Ile-de-France/Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.
  • Hagiu DP; Emerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
  • Mueller JE; LIP/PC2S, Université Grenoble Alpes, Grenoble, France.
  • Gagneux-Brunon A; LIP/PC2S, Université Savoie Mont Blanc, Chambéry, France.
  • Thilly N; SPHERE U1246, Université de Tours, Université de Nantes, INSERM, Tours, France.
Health Expect ; 26(5): 1843-1853, 2023 10.
Article em En | MEDLINE | ID: mdl-37312280
ABSTRACT

INTRODUCTION:

Despite various efforts to improve human papillomavirus (HPV) vaccine coverage in France, it has always been lower than in most other high-income countries. The health authorities launched in 2018 the national PrevHPV research programme to (1) co-develop with stakeholders and (2) evaluate the impact of a multicomponent complex intervention aimed at improving HPV vaccine coverage amongst French adolescents.

OBJECTIVE:

To describe the development process of the PrevHPV intervention using the GUIDance for rEporting of intervention Development framework as a guide.

METHODS:

To develop the intervention, we used findings from (1) published evidence on effective strategies to improve vaccination uptake and on theoretical frameworks of health behaviour change; (2) primary data on target populations' knowledge, beliefs, attitudes, preferences, behaviours and practices as well as the facilitators and barriers to HPV vaccination collected as part of the PrevHPV Programme and (3) the advice of working groups involving stakeholders in a participatory approach. We paid attention to developing an intervention that would maximise reach, adoption, implementation and maintenance in real-world contexts.

RESULTS:

We co-developed three components (1) adolescents' and parents' education and motivation using eHealth tools (web conferences, videos, and a serious video game) and participatory learning at school; (2) general practitioners' e-learning training on HPV using motivational interviewing techniques and provision of a decision aid tool and (3) easier access to vaccination through vaccination days organised on participating middle schools' premises to propose free of charge initiation of the HPV vaccination.

CONCLUSION:

We co-developed a multicomponent intervention that addresses a range of barriers and enablers of HPV vaccination. The next step is to build on the results of its evaluation to refine it before scaling it up if proven efficient. If so, it will add to the small number of multicomponent interventions aimed at improving HPV vaccination worldwide. PATIENT OR PUBLIC CONTRIBUTION The public (adolescents, their parents, school staff and health professionals) participated in the needs assessment using a mixed methods approach. The public was also involved in the components' development process to generate ideas about potential activities/tools, critically revise the successive versions of the tools and provide advice about the intervention practicalities, feasibility and maintenance.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article